What are the informations I should know about Arcoxia (Etoricoxib)?
• Arcoxia (Etoricoxib) is the newset of the COX-II inhibitors released onto the market by Merck Frosst. Arcoxia (Etoricoxib) can be used to treat acute gouty arthritis, osteoarthirtis and other conditions as determined by your doctor. • Arcoxia (Etoricoxib) is administered orally and may be taken with or without food. The onset of Arcoxia (Etoricoxib) effect may be faster when Arcoxia (Etoricoxib) is administered without food. This should be considered when rapid symptomatic relief is needed. Osteoarthritis: The recommended dose of Arcoxia (Etoricoxib) is 60 mg once daily. Rheumatoid arthritis- The recommended dose is 90 mg once daily. Acute gouty arthritis- The recommended dose of Arcoxia (Etoricoxib) is 120 mg once daily. In clinical trials for acute gouty arthritis, Arcoxia (Etoricoxib) was given for 8 days. Doses greater than those recommended for each indication have either not demonstrated additional efficacy or have not been studied. Therefore, the dose for each indication is th
